A Reference Broth Microdilution Method for Dalbavancin <em>In Vitro</em> Susceptibility Testing of Bacteria that Grow Aerobically

Abstract

Antimicrobial susceptibility testing (AST) is performed to assess the in vitro activity of antimicrobial agents against various bacteria. The AST results, which are expressed as minimum inhibitory concentrations (MICs) are used in research for antimicrobial development and monitoring of resistance development and in the clinical setting for antimicrobial therapy guidance. Dalbavancin is a semi-synthetic lipoglycopeptide antimicrobial agent that was approved in May 2014 by the Food and Drug Administration (FDA) for the treatment of acute bacterial skin and skin structure infections caused by Gram-positive organisms. The advantage of dalbavancin over current anti-staphylococcal therapies is its long half-life, which allows for once-weekly dosing. Dalbavancin has activity against Staphylococcus aureus (including both methicillin-susceptible S. aureus [MSSA] and methicillin-resistant S. aureus [MRSA]), coagulase-negative staphylococci, Streptococcus pneumoniae, Streptococcus anginosus group, β-hemolytic streptococci and vancomycin susceptible enterococci. Similar to other recent lipoglycopeptide agents, optimization of CLSI and ISO broth susceptibility test methods includes the use of dimethyl sulfoxide (DMSO) as a solvent when preparing stock solutions and polysorbate 80 (P80) to alleviate adherence of the agent to plastic. Prior to the clinical studies and during the initial development of dalbavancin, susceptibility studies were not performed with the use of P-80 and MIC results tended to be 2-4 fold higher and similarly higher MIC results were obtained with the agar dilution susceptibility method. Dalbavancin was first included in CLSI broth microdilution methodology tables in 2005 and amended in 2006 to clarify use of DMSO and P-80. The broth microdilution (BMD) procedure shown here is specific to dalbavancin and is in accordance with the CLSI and ISO methods, with step-by-step detail and focus on the critical steps added for clarity.

Novel 2-Substituted 3-Hydroxy-1,6-dimethylpyridin-4(1H)-ones as Dual-Acting Biofilm Inhibitors of Pseudomonas aeruginosa

“…A broth-microdilution method from standards published by the Clinical and Laboratory Standards Institute , was employed to determine compounds’ minimum inhibitory concentrations (MICs). Briefly, 2-fold serial dilutions of compounds were conducted in Muller–Hinton broth (Sangon Biotech, China) at a volume of 200 μL per well in 96-well U-bottomed polystyrene microtiter plates (Corning/Costar, NY, USA).…”

Molecular Characteristics of IS 1216 Carrying Multidrug Resistance Gene Cluster in Serotype III/Sequence Type 19 Group B Streptococcus

“…The broth microdilution test was used to determine the antimicrobial susceptibilities of GBS non- srr1/2 clinical isolates to amikacin (AMK), gentamicin (GEN), kanamycin (KAN), spectinomycin (SPT), streptomycin (STR), tobramycin (TOB), clindamycin (CLI), and lincomycin (LIN) as described previously ( 71 , 72 ). Briefly, GBS was inoculated in Todd-Hewitt broth supplemented with yeast extract (THY) and incubated overnight at 37°C.…”

Antimicrobial and Anti-inflammatory Effects of α-Mangostin Soluble Film

“…Samples of soluble film containing α-MG were tested against three organisms, S. mutans, P.gingivalis , and C. albican s, for their inhibitory activity using a broth microdilution method. [ 19 ] Briefly, 100 µL of the serially diluted samples (from 234 to 3.66 µg/mL) was added to each well plate; 10 µL of microbial suspension was added at the starting optical density at 10 5 CFU/mL to the sample well plates. The microtiter plates were incubated under the appropriate conditions for each microbial mentioned earlier.…”

“…Time-killing kinetic studies against organisms were determined by the broth microdilution method. [ 19 ] The culture of organisms was diluted to 10 7 CFU/mL. The diluted microbial cultures were treated with the sample of α-MG soluble film (234 µg/mL).…”

“…The effects of α-MG soluble film on microbial biofilm formation were tested by the broth microdilution method. [ 19 ] Briefly, a concentration of the sample of α-MG soluble film (234 µg/mL) in culture media was added at a volume of 100 µL per well. Microbial cultures (10 µL) were added to the final concentration at 1 × 10 7 CFU/mL to the culture well, whereas the medium only was added as a blank control.…”